Evoke Pharma’s Gimoti NDA Accepted for FDA Review

Treatment for Gastroparesis Evoke Pharma’s Gimoti NDA Accepted for FDA Review Print this page SOLANA BEACH, Calif., Aug. 16, 2018 (GLOBE NEWSWIRE) — Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty […]

Complete Response Letter Issued for Remoxy

Treatment for Pain Complete Response Letter Issued for Remoxy Print this page AUSTIN, Texas, Aug. 06, 2018 (GLOBE NEWSWIRE) — Pain Therapeutics, Inc. (Nasdaq: PTIE) today announced it had received […]

Ocular Therapeutix Announces NDA Resubmission of Dextenza

Treatment for Postoperative Ocular Inflammation Ocular Therapeutix Announces NDA Resubmission of Dextenza Print this page BEDFORD, Mass.–(BUSINESS WIRE)–Jun. 29, 2018– Ocular Therapeutix™, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on […]